{"id":"W2553811141","doi":"10.1182/blood.v106.11.349.349","title":"Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Hazard ratio; Internal medicine; Vincristine; Gastroenterology; Randomization; Cyclophosphamide; Prednisone; Surgery; Lymphoma; Chemotherapy; Confidence interval; Oncology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002893118,0.0006083664,0.001137237,0.000264904,0.0001860753,0.0006241315,0.0007303882,0.0009515709,0.001453006],"category_scores_gemma":[0.001226346,0.0002361302,0.0009544661,0.0002490627,0.0006292513,0.0005497747,0.000300439,0.002301306,0.0004214941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005308447,"about_ca_system_score_gemma":0.0004728285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000414296,"about_ca_topic_score_gemma":0.0008238067,"domain_scores_codex":[0.9993462,0.0004095128,0.00003190768,0.000078162,0.00004780733,0.00008642212],"domain_scores_gemma":[0.9991405,0.0002546962,0.0001633501,0.0001073458,0.00003135455,0.000302779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7596709,0.02337766,0.01110445,0.0005495621,0.001356801,0.0002111084,0.0001628536,0.001887257,0.03297013,0.0003774345,0.003933929,0.164398],"study_design_scores_gemma":[0.436506,0.5147386,0.03698131,0.00007366863,0.0009903689,0.0004401479,0.00004024124,0.00221784,0.004403665,0.000368247,0.003200844,0.0000389953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948196,0.002711466,0.0002514361,0.0003463153,0.00009925497,0.000339147,0.0003592983,0.0000324196,0.001041076],"genre_scores_gemma":[0.9957106,0.0009183725,0.0006201181,0.0006328647,0.0001576498,0.0002913723,0.0008845949,0.00001359086,0.0007708609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002893118,"threshold_uncertainty_score":0.01530045,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02303963769587453,"score_gpt":0.3321429067956527,"score_spread":0.3091032690997781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}